Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube Cancer
Clinical trial NCT04991051 · COMPLETED
Trial details
- NCT number
- NCT04991051
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-02
- Primary completion
- 2022-08-15
- Enrollment
- 605
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.